These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3434462)

  • 1. Reduction of dopamine receptor activity differentially alters striatal neuropeptide mRNA levels.
    Angulo JA; Christoph GR; Manning RW; Burkhart BA; Davis LG
    Adv Exp Med Biol; 1987; 221():385-91. PubMed ID: 3434462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K; Wictorin K; Björklund A
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Neurosci Lett; 1990 May; 113(2):217-21. PubMed ID: 1974041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma receptor blockade by BMY 14802 affects enkephalinergic and tachykinin cells differentially in the striatum of the rat.
    Angulo JA; Cadet JL; McEwen BS
    Eur J Pharmacol; 1990 Jan; 175(2):225-8. PubMed ID: 1968844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ; Hunt SP
    Neurosci Lett; 1991 Apr; 125(2):201-4. PubMed ID: 1831887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ; Schotte A; Docter GJ; Voorn P
    Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization.
    Romano GJ; Shivers BD; Harlan RE; Howells RD; Pfaff DW
    Brain Res; 1987 Apr; 388(1):33-41. PubMed ID: 3580841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
    Jaber M; Tison F; Fournier MC; Bloch B
    Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum.
    Laprade N; Soghomonian JJ
    Brain Res Mol Brain Res; 1995 Dec; 34(1):65-74. PubMed ID: 8750862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts.
    Mendez IM; Naus CC; Elisevich K; Flumerfelt BA
    Exp Neurol; 1993 Jan; 119(1):1-10. PubMed ID: 8432341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
    Morris BJ; Höllt V; Herz A
    Neuroscience; 1988 May; 25(2):525-32. PubMed ID: 3041310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with pentazocine or SFK 10047 decrease proenkephalin mRNA levels in the rat striatum and nucleus accumbens.
    Angulo JA; Ledoux M; McEwen BS
    Neurosci Lett; 1991 Jan; 122(1):47-9. PubMed ID: 1647506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ
    J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 58261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum.
    Wardas J; Pietraszek M; Dziedzicka-Wasylewska M
    Brain Res; 2003 Jul; 977(2):270-7. PubMed ID: 12834887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.
    Wardas J; Pietraszek M; Wolfarth S; Ossowska K
    Neuroscience; 2003; 122(3):747-56. PubMed ID: 14622918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid regulation of neuropeptide mRNAs in the rat striatum.
    Chao HM; McEwen BS
    Brain Res Mol Brain Res; 1991 Mar; 9(4):307-11. PubMed ID: 1645434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.